Lindbrook Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,145 shares of REGN stock, worth $847,311. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,145

Previous 1,159 1.21%

Holding current value

$847,311

Previous $1.22 Million 1.23%

% of portfolio

0.1%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$1024.09 - $1201.76 $14,337 - $16,824	-14 Reduced 1.21%	1,145 $1.2 Million
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $35,328 - $42,847	40 Added 3.57%	1,159 $1.22 Million
Q1 2024 Apr 25, 2024	BUY	$902.69 - $993.35 $13,540 - $14,900	15 Added 1.36%	1,119 $1.08 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $57,363 - $65,245	74 Added 7.18%	1,104 $969,000
Q3 2023 Oct 25, 2023	BUY	$692.45 - $844.37 $25,620 - $31,241	37 Added 3.73%	1,030 $847,000
Q2 2023 Jul 28, 2023	SELL	$700.03 - $830.35 $33,601 - $39,856	-48 Reduced 4.61%	993 $713,000
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $53,758 - $65,330	79 Added 8.21%	1,041 $855,000
Q4 2022 Jan 24, 2023	BUY	$705.89 - $766.39 $24,000 - $26,057	34 Added 3.66%	962 $0
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $19,514 - $24,626	34 Added 3.8%	928 $639,000
Q2 2022 Aug 01, 2022	SELL	$548.35 - $738.84 $9,321 - $12,560	-17 Reduced 1.87%	894 $528,000
Q1 2022 Apr 21, 2022	BUY	$595.12 - $698.43 $7,736 - $9,079	13 Added 1.45%	911 $636,000
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $543 - $670	-1 Reduced 0.11%	898 $567,000
Q3 2021 Nov 05, 2021	BUY	$574.03 - $680.96 $4,592 - $5,447	8 Added 0.9%	899 $544,000
Q2 2021 Jul 27, 2021	BUY	$472.8 - $558.54 $24,112 - $28,485	51 Added 6.07%	891 $498,000
Q1 2021 Apr 28, 2021	SELL	$446.73 - $548.2 $17,422 - $21,379	-39 Reduced 4.44%	840 $397,000
Q4 2020 Jan 27, 2021	BUY	$478.3 - $607.98 $24,393 - $31,006	51 Added 6.16%	879 $425,000
Q3 2020 Nov 03, 2020	SELL	$544.75 - $658.21 $24,513 - $29,619	-45 Reduced 5.15%	828 $463,000
Q2 2020 Jul 27, 2020	BUY	$493.32 - $643.92 $5,426 - $7,083	11 Added 1.28%	873 $544,000
Q1 2020 Apr 22, 2020	SELL	$336.18 - $494.43 $1,008 - $1,483	-3 Reduced 0.35%	862 $421,000
Q4 2019 Jan 27, 2020	BUY	$274.13 - $376.51 $1,370 - $1,882	5 Added 0.58%	865 $325,000
Q3 2019 Oct 31, 2019	BUY	$273.46 - $318.39 $18,595 - $21,650	68 Added 8.59%	860 $239,000
Q2 2019 Jul 24, 2019	SELL	$299.6 - $414.82 $14,380 - $19,911	-48 Reduced 5.71%	792 $247,000
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $282,088 - $338,553	840 New	840 $313,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History